{"transactions":[{"id":686992,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-14T20:16:36.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":5145,"price":4.42,"value":22740.9,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":99630,"source":{"system":"sec-edgar","filing":"0001104659-26-097192","document":"tm2623285-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926097192/tm2623285-3_4seq1.xml","form_type":"4"}},{"id":726438,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T20:21:37.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":21277,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":21277,"derivative":{"exercise_price":4.04,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":21277},"source":{"system":"sec-edgar","filing":"0001104659-26-077780","document":"tm2618965-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926077780/tm2618965-6_4seq1.xml","form_type":"4"}},{"id":726437,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T20:21:37.000Z","date":"2026-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":4261,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of RSUs. No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":104775,"source":{"system":"sec-edgar","filing":"0001104659-26-077780","document":"tm2618965-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926077780/tm2618965-6_4seq1.xml","form_type":"4"}},{"id":726436,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-06-25T20:21:37.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":17327,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on June 23, 2026 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":109036,"source":{"system":"sec-edgar","filing":"0001104659-26-077780","document":"tm2618965-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926077780/tm2618965-6_4seq1.xml","form_type":"4"}},{"id":775174,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-18T12:00:06.000Z","date":"2026-05-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.13,"value":82600.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":91709,"source":{"system":"sec-edgar","filing":"0001104659-26-063015","document":"tm2614903-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926063015/tm2614903-1_4seq1.xml","form_type":"4"}},{"id":1056863,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-08-25T23:04:50.000Z","date":"2025-08-25","kind":"purchase","planned":false,"acquired":true,"shares":5760,"price":2.61,"value":15033.6,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $2.61. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":71709,"source":{"system":"sec-edgar","filing":"0001104659-25-082638","document":"tm2524324-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925082638/tm2524324-4_4seq1.xml","form_type":"4"}},{"id":1071429,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T23:12:42.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on August 7, 2025 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":58449,"source":{"system":"sec-edgar","filing":"0001104659-25-075784","document":"tm2523004-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925075784/tm2523004-5_4seq1.xml","form_type":"4"}},{"id":1071428,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-08-08T23:12:42.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on August 7, 2025 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001104659-25-075784","document":"tm2523004-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925075784/tm2523004-5_4seq1.xml","form_type":"4"}},{"id":1100339,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-06-27T21:10:00.000Z","date":"2025-06-26","kind":"sale","planned":false,"acquired":false,"shares":2683,"price":3.05,"value":8183.15,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on June 20, 2024 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.11, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50949,"source":{"system":"sec-edgar","filing":"0001104659-25-063693","document":"tm2519252-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925063693/tm2519252-7_4seq1.xml","form_type":"4"}},{"id":1101111,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-26T21:15:39.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":36797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates."}],"balance_after":36797,"derivative":{"exercise_price":3.22,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":36797},"source":{"system":"sec-edgar","filing":"0001104659-25-063094","document":"tm2519252-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925063094/tm2519252-2_4seq1.xml","form_type":"4"}},{"id":1101110,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-06-26T21:15:39.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":12422,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on June 24, 2025 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates."}],"balance_after":53632,"source":{"system":"sec-edgar","filing":"0001104659-25-063094","document":"tm2519252-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925063094/tm2519252-2_4seq1.xml","form_type":"4"}},{"id":1410907,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-10T23:43:55.000Z","date":"2024-09-10","kind":"sale","planned":false,"acquired":false,"shares":1800,"price":5.34,"value":9612.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.14 to $5.69, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41210,"source":{"system":"sec-edgar","filing":"0001104659-24-098692","document":"tm2423769-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924098692/tm2423769-1_4seq1.xml","form_type":"4"}},{"id":1410906,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-10T23:43:55.000Z","date":"2024-09-09","kind":"sale","planned":false,"acquired":false,"shares":1800,"price":5.43,"value":9774.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.53, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":43010,"source":{"system":"sec-edgar","filing":"0001104659-24-098692","document":"tm2423769-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924098692/tm2423769-1_4seq1.xml","form_type":"4"}},{"id":1410905,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-09-10T23:43:55.000Z","date":"2024-09-06","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":5.64,"value":11280.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units (\"RSUs\"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.54 to $5.78, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the \"SEC\"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44810,"source":{"system":"sec-edgar","filing":"0001104659-24-098692","document":"tm2423769-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924098692/tm2423769-1_4seq1.xml","form_type":"4"}},{"id":1472164,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:55:29.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":17068,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"balance_after":17068,"derivative":{"exercise_price":7.44,"exercise_date":"2025-06-20","expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":17068},"source":{"system":"sec-edgar","filing":"0001104659-24-074010","document":"tm2417742-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924074010/tm2417742-2_4seq1.xml","form_type":"4"}},{"id":1472163,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-06-21T21:55:29.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":5376,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 20, 2025."}],"balance_after":46810,"source":{"system":"sec-edgar","filing":"0001104659-24-074010","document":"tm2417742-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924074010/tm2417742-2_4seq1.xml","form_type":"4"}},{"id":1824224,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-24T21:08:34.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"balance_after":17500,"derivative":{"exercise_price":7.42,"exercise_date":"2024-07-20","expiration_date":"2033-07-20","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001104659-23-083495","document":"tm2321855-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923083495/tm2321855-1_4seq1.xml","form_type":"4"}},{"id":1824223,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-07-24T21:08:34.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on the first anniversary of the grant date."}],"balance_after":41434,"source":{"system":"sec-edgar","filing":"0001104659-23-083495","document":"tm2321855-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923083495/tm2321855-1_4seq1.xml","form_type":"4"}},{"id":1884803,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-05-19T21:48:07.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":23250,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently misstated the expiration date of one class of nonstatutory stock options (\"NSOs\"). In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to correct the incorrect expiration date in Table II, Column 6 to August 17, 2032; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 50,000 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares will vest on the first anniversary of the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis, starting on the day of the month of the last month of the first quarter after the first anniversary of the grant date, that is the same day of the month as the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022."}],"balance_after":23250,"derivative":{"exercise_price":10,"expiration_date":"2032-08-17","underlying":"Common Stock","underlying_shares":23250},"source":{"system":"sec-edgar","filing":"0001213900-23-041625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023041625/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1895206,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-05-12T20:59:08.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":2906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"balance_after":0,"derivative":{"exercise_price":1.08,"exercise_date":"2023-01-26","expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2906},"source":{"system":"sec-edgar","filing":"0001213900-23-039101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023039101/ownership.xml","form_type":"4"}},{"id":1895205,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-05-12T20:59:08.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":2906,"price":1.08,"value":3138.48,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"balance_after":29767,"source":{"system":"sec-edgar","filing":"0001213900-23-039101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023039101/ownership.xml","form_type":"4"}},{"id":1902974,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-06T00:14:52.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":false,"shares":4796,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 4,796 shares of Common Stock were issued to the Fain Living Trust on April 19, 2023 in accordance with the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 4,796 shares of Common Stock were issued to the Fain Living Trust on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 4,796 shares of Common Stock were issued to the Fain Living Trust on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 4,796 shares of Common Stock were issued to the Fain Living Trust on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 4,796 shares of Common Stock were issued to the Fain Living Trust on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":4796,"derivative":{"underlying":"Common Stock","underlying_shares":4796},"source":{"system":"sec-edgar","filing":"0001213900-23-037021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037021/ownership.xml","form_type":"4"}},{"id":1902973,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-05-06T00:14:52.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":true,"shares":4796,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 4,796 shares of Common Stock were issued to the Fain Living Trust on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 4,796 shares of Common Stock were issued to the Fain Living Trust on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":26861,"source":{"system":"sec-edgar","filing":"0001213900-23-037021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037021/ownership.xml","form_type":"4"}},{"id":1902963,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-05T23:47:52.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":9592,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently omitted the right to receive Earnout Shares (defined below). In accordance with Instruction 9(a) to Form 4, this amendment is filed solely to add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."}],"balance_after":9592,"derivative":{"underlying":"Common Stock","underlying_shares":9592},"source":{"system":"sec-edgar","filing":"0001213900-23-037004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037004/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":2042303,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-01-31T02:29:47.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":2906,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in the Business Combination in exchange for warrants to purchase 6,250 shares of Legacy Orchestra Common Stock for $0.50 per share."}],"balance_after":2906,"derivative":{"exercise_price":1.08,"exercise_date":"2023-01-26","expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2906},"source":{"system":"sec-edgar","filing":"0001213900-23-006184","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006184/ownership.xml","form_type":"4"}},{"id":2042302,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:29:47.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":23250,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 50,000 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The nonstatutory stock options vest over a three-year period as follows: (i) 33% of the underlying shares will vest on the first anniversary of the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis, starting on the day of the month of the last month of the first quarter after the first anniversary of the grant date, that is the same day of the month as the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022."}],"balance_after":23250,"derivative":{"exercise_price":10,"expiration_date":"2032-08-25","underlying":"Common Stock","underlying_shares":23250},"source":{"system":"sec-edgar","filing":"0001213900-23-006184","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006184/ownership.xml","form_type":"4"}},{"id":2042301,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:29:47.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":6975,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 15,000 shares of Legacy Orchestra Common Stock for $2.00 per share."}],"balance_after":6975,"derivative":{"exercise_price":4.3,"exercise_date":"2023-01-26","expiration_date":"2029-08-06","underlying":"Common Stock","underlying_shares":6975},"source":{"system":"sec-edgar","filing":"0001213900-23-006184","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006184/ownership.xml","form_type":"4"}},{"id":2042300,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:29:47.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":18600,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 40,000 shares of Legacy Orchestra Common Stock for $2.00 per share."}],"balance_after":18600,"derivative":{"exercise_price":4.3,"exercise_date":"2023-01-26","expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001213900-23-006184","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006184/ownership.xml","form_type":"4"}},{"id":2042299,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-01-31T02:29:47.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":22065,"ownership":{"direct":false,"nature":"By the Fain Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued on the closing date of the merger (the \"Business Combination\") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the \"Merger Agreement\"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) (\"HSAC2\"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation (\"Legacy Orchestra\"), in exchange for Legacy Orchestra securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in the Business Combination in exchange for 47,450 shares of common stock of Legacy Orchestra (\"Legacy Orchestra Common Stock\")."}],"balance_after":22065,"source":{"system":"sec-edgar","filing":"0001213900-23-006184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006184/ownership.xml","form_type":"4"}},{"id":423254,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-09-29T21:10:53.000Z","date":"2017-07-21","kind":"disposition_to_issuer","acquired":false,"shares":23085,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":493961,"source":{"system":"sec-edgar","filing":"0001179110-17-012768","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017012768/edgar.xml","form_type":"4/A","original_submission_date":"2017-07-25"}},{"id":424566,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-07-25T22:38:24.000Z","date":"2017-07-21","kind":"tax_withholding","acquired":false,"shares":1524,"price":50.84,"value":77480.16,"ownership":{"direct":true},"balance_after":517046,"source":{"system":"sec-edgar","filing":"0001179110-17-010671","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010671/edgar.xml","form_type":"4"}},{"id":424565,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-07-25T22:38:24.000Z","date":"2017-07-21","kind":"tax_withholding","acquired":false,"shares":26488,"price":50.85,"value":1346914.8,"ownership":{"direct":true},"balance_after":518570,"source":{"system":"sec-edgar","filing":"0001179110-17-010671","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010671/edgar.xml","form_type":"4"}},{"id":424570,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-07-25T22:37:31.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":114240,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Due to an administrative error that occurred prior to Abbott's acquisition of St. Jude Medical, Inc., the Form 4 filed on January 6, 2017 underreported the Abbott shares received by the reporting person pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Inc., Vault Merger Sub, Inc., and Vault Merger Sub, LLC, by 413 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 4, 2017, Abbott Laboratories (\"Abbott\") acquired St. Jude Medical, Inc. (\"St. Jude Medical\") pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Vault Merger Sub, Inc. and Vault Merger Sub, LLC dated as of April 27, 2016 (the \"Merger Agreement\"). Upon the First Effective Time (as defined in the Merger Agreement), each outstanding St. Jude Medical common share (other than certain shares identified in the Merger Agreement) was converted into the right to receive (a) $46.75 in cash, without interest, and (b) 0.8708 common shares of Abbott."}],"balance_after":116333,"source":{"system":"sec-edgar","filing":"0001179110-17-010670","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010670/edgar.xml","form_type":"4/A","original_submission_date":"2017-01-06"}},{"id":429761,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-02-22T22:19:49.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":159657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 53,219 on 02/17/2018, 53,219 on 02/17/2019, and 53,219 on 02/17/2020."}],"balance_after":159657,"derivative":{"exercise_price":44.4,"exercise_date":"2018-02-17","expiration_date":"2027-02-16","underlying":"Common shares","underlying_shares":159657},"source":{"system":"sec-edgar","filing":"0001179110-17-002920","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002920/edgar.xml","form_type":"4"}},{"id":429760,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-02-22T22:19:49.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":23085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to administrative error, the previously reported beneficial ownership for this reporting person was overstated by 1 share.  This Form 4 reflects the corrected total beneficial ownership for this reporting person."}],"balance_after":544052,"source":{"system":"sec-edgar","filing":"0001179110-17-002920","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002920/edgar.xml","form_type":"4"}},{"id":431953,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-01-06T22:28:57.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":163268,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"54,422 options are scheduled to vest on December 17, 2017, 54,422 options are scheduled to vest on December 17, 2018 and 54,424 options are scheduled to vest on January 4, 2019."}],"balance_after":163268,"derivative":{"exercise_price":29.56,"expiration_date":"2023-12-07","underlying":"Common shares without par value","underlying_shares":163268},"source":{"system":"sec-edgar","filing":"0001104659-17-001246","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001246/a4.xml","form_type":"4"}},{"id":431952,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-01-06T22:28:57.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":85864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"42,932 options are scheduled to vest on December 17, 2017 and 42,932 options are scheduled to vest on December 17, 2018."}],"balance_after":85864,"derivative":{"exercise_price":33.14,"expiration_date":"2022-12-08","underlying":"Common shares without par value","underlying_shares":85864},"source":{"system":"sec-edgar","filing":"0001104659-17-001246","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001246/a4.xml","form_type":"4"}},{"id":431951,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-01-06T22:28:57.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":44387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These options are scheduled to vest on December 17, 2017."}],"balance_after":44387,"derivative":{"exercise_price":28.5,"expiration_date":"2021-12-10","underlying":"Common shares without par value","underlying_shares":44387},"source":{"system":"sec-edgar","filing":"0001104659-17-001246","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001246/a4.xml","form_type":"4"}},{"id":431950,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-01-06T22:28:57.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":32418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical restricted stock unit award was canceled and converted into a restricted stock unit award, with substantially the same terms and conditions as were applicable to such St. Jude Medical award (except that, subject to the holder's continued employment, the award will fully vest to the extent unvested on the second anniversary of the First Effective Time), that is settleable with respect to a number of Abbott common shares equal to the product (rounded to the nearest whole share) of (a) the number of St. Jude Medical shares subject to such award multiplied by (b)  2.0850 (the \"Stock Award Exchange Ratio\")."},{"field":"shares","element":"transactionShares","label":"F6","text":"15,982 restricted stock units are scheduled to vest on December 17, 2017 and will be settled promptly thereafter, 10,657 restricted stock units are scheduled to vest on December 17, 2018 and will be settled promptly thereafter, and 5,779 restricted stock units are scheduled to vest on January 4, 2019 and will be settled December 17, 2019."}],"balance_after":520968,"source":{"system":"sec-edgar","filing":"0001104659-17-001246","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001246/a4.xml","form_type":"4"}},{"id":431949,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-01-06T22:28:57.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":50761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares represent restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program.  These awards have a 3-year term and are scheduled to vest on January 4, 2020.  The award includes the right to have shares withheld for tax purposes."}],"balance_after":488549,"source":{"system":"sec-edgar","filing":"0001104659-17-001246","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001246/a4.xml","form_type":"4"}},{"id":431948,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-01-06T22:28:57.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":322461,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each vested St. Jude Medical stock option was deemed exercised pursuant to a cashless exercise and deemed settled by issuance of a number of St. Jude Medical shares equal to the difference (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (a) the number of St. Jude Medical common shares subject to such surrendered St. Jude Medical option as of immediately prior to the First Effective Time minus (b) the number of whole and partial (computed to the nearest four decimal places) St. Jude Medical common shares that, when multiplied by $80.82 (the closing price of a St. Jude Medical common share on January 4, 2017), is equal to the aggregate exercise price of such surrendered St. Jude Medical option. (Continued in footnote 3)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Such St. Jude Medical common shares were then canceled and converted into the right to receive the merger consideration with respect to each St. Jude Medical common share issued in respect of the stock option, less any applicable withholding taxes."}],"balance_after":437788,"source":{"system":"sec-edgar","filing":"0001104659-17-001246","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001246/a4.xml","form_type":"4"}},{"id":431947,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-01-06T22:28:57.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":113827,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 4, 2017, Abbott Laboratories (\"Abbott\") acquired St. Jude Medical, Inc. (\"St. Jude Medical\") pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Vault Merger Sub, Inc. and Vault Merger Sub, LLC dated as of April 27, 2016 (the \"Merger Agreement\").  Upon the First Effective Time (as defined in the Merger Agreement), each outstanding St. Jude Medical common share (other than certain shares identified in the Merger Agreement) was converted into the right to receive (a) $46.75 in cash, without interest, and (b) 0.8708 common shares of Abbott."}],"balance_after":115327,"source":{"system":"sec-edgar","filing":"0001104659-17-001246","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001246/a4.xml","form_type":"4"}},{"id":4497302,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":8316,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8316},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497301,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":104408,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":61.62,"exercise_date":"2016-12-17","expiration_date":"2023-12-07","underlying":"Common Stock","underlying_shares":104408},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497300,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":4678,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4678},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497299,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":82364,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":69.08,"exercise_date":"2015-12-17","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":82364},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497298,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":2554,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2554},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497297,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":85156,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":59.41,"exercise_date":"2014-12-17","expiration_date":"2021-12-10","underlying":"Common Stock","underlying_shares":85156},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497296,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":35.27,"exercise_date":"2013-12-17","expiration_date":"2020-12-10","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497295,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":34.96,"exercise_date":"2012-12-17","expiration_date":"2019-12-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497294,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":144500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":41.65,"exercise_date":"2011-12-14","expiration_date":"2018-12-14","underlying":"Common Stock","underlying_shares":144500},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497293,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":140000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":38.59,"exercise_date":"2010-12-14","expiration_date":"2017-12-14","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4497292,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2017-01-06T13:11:34.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":130716,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories (\"Abbott\"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the \"Merger Agreement\"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the \"Merger Consideration\"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-000586","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000586/edgar.xml","form_type":"4"}},{"id":4516262,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":2772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":8316,"derivative":{"exercise_date":"2016-12-17","underlying":"Common Stock","underlying_shares":11088},"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516261,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":2339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":4678,"derivative":{"exercise_date":"2015-12-17","underlying":"Common Stock","underlying_shares":7017},"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516260,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":2554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":2554,"derivative":{"exercise_date":"2014-12-17","underlying":"Common Stock","underlying_shares":5108},"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516259,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":0,"derivative":{"exercise_date":"2013-12-17","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516258,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":1453,"price":79.2,"value":115077.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"2,772 shares of restricted stock vested on December 17, 2016. 1,453 shares were used to pay taxes and 1,319 shares were released."}],"balance_after":130716,"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516257,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":2772,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":132169,"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516256,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":127,"price":79.2,"value":10058.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"2,339 shares of restricted stock vested on December 17, 2016. 1,227 shares were used to pay taxes and 1,112 shares were released."}],"balance_after":129397,"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516255,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":2339,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":130624,"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516254,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":1342,"price":79.2,"value":106286.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"2,554 shares of restricted stock vested on December 17, 2016. 1,342 shares were used to pay taxes and 1,212 shares were released."}],"balance_after":128285,"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516253,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":2554,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":129627,"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516252,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":2102,"price":79.2,"value":166478.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"4,000 shares of restricted stock vested on December 17, 2016. 2102 shares were used to pay taxes and 1898 shares were released."}],"balance_after":127073,"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4516251,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-20T17:01:49.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":129175,"source":{"system":"sec-edgar","filing":"0001179110-16-033308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033308/edgar.xml","form_type":"4"}},{"id":4519835,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-16T16:23:14.000Z","date":"2016-12-14","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested at the time of filing."}],"balance_after":0,"derivative":{"exercise_price":30.58,"exercise_date":"2009-12-15","expiration_date":"2016-12-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-16-033105","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033105/edgar.xml","form_type":"4"}},{"id":4519834,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-16T16:23:14.000Z","date":"2016-12-14","kind":"tax_withholding","acquired":false,"shares":104917,"price":79.76,"value":8368179.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares of common stock withheld to pay the exercise price of the stock options and to pay tax withholdings.  The 150,000 shares acquired upon the option exercise, net of 104,917 shares used to pay exercise price and taxes, resulted in 45,083 shares that were retained."}],"balance_after":125175,"source":{"system":"sec-edgar","filing":"0001179110-16-033105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033105/edgar.xml","form_type":"4"}},{"id":4519833,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-16T16:23:14.000Z","date":"2016-12-14","kind":"exercise","acquired":true,"shares":150000,"price":30.58,"value":4587000.0,"ownership":{"direct":true},"balance_after":230092,"source":{"system":"sec-edgar","filing":"0001179110-16-033105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033105/edgar.xml","form_type":"4"}},{"id":4519832,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16158,"kind":"person","name":"Fain Eric S","position":1,"cik":"0001402222","reported_name":"Fain Eric S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2016-12-16T16:23:14.000Z","date":"2016-12-12","kind":"gift","acquired":false,"shares":200,"price":80.2,"value":16040.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 338 additional shares acquired through the Company Employee Stock Purchase Plan on July 29, 2016."}],"balance_after":80092,"source":{"system":"sec-edgar","filing":"0001179110-16-033105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033105/edgar.xml","form_type":"4"}}]}